Single-Arm, Open-Label Phase 2 Trial of Preemptive Methylprednisolone to Avert Progression to Respiratory Failure in High-Risk Patients with COVID-19

por Cabanillas 1,5, Fernando, Morales 2, Javier, Conde 3, José G., Bertrán-Pasarell 1, Jorge, Fernández 4, Ricardo, Hernandez-Silva 5, Yaimara, Liboy 5, Idalia, Bryan-Díaz 5, James, Arraut-Gonzalez 5, Juan
Publicado 2021